EMA recommends approval of treatment for attention deficit hyperactivity disorder

View source ↗

Summary

EMA recommends approval of a new treatment for attention deficit hyperactivity disorder, indicating positive assessment of its benefit-risk profile for ADHD.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Attention Deficit Hyperactivity Disorder